GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Total Revenue Growth Rate (Future 3Y To 5Y Est)

Pharma Mar (XMAD:PHM) Total Revenue Growth Rate (Future 3Y To 5Y Est) : N/A (As of May. 26, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Total Revenue Growth Rate (Future 3Y To 5Y Est)?

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, Pharma Mar's Total Revenue Growth Rate (Future 3Y To 5Y Est) is N/A.


Competitive Comparison of Pharma Mar's Total Revenue Growth Rate (Future 3Y To 5Y Est)

For the Biotechnology subindustry, Pharma Mar's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar's Total Revenue Growth Rate (Future 3Y To 5Y Est) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.



Pharma Mar  (XMAD:PHM) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.


Pharma Mar Total Revenue Growth Rate (Future 3Y To 5Y Est) Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Mar (XMAD:PHM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Total Revenue Growth Rate (Future 3Y To 5Y Est)
Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar (XMAD:PHM) Headlines

From GuruFocus

Q3 2021 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2022 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Pultegroup Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Q2 2019 PulteGroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2020 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2019 PulteGroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2020 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024